JAK2(V617F) mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders.
Ohyashiki
K
K
Aota
Y
Y
Akahane
D
D
Gotoh
A
A
Ohyashiki
J H
JH
D000328:Adult; D000368:Aged; D001483:Base Sequence; D002908:Chronic Disease; D017931:DNA Primers; D005260:Female; D005453:Fluorescence; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000235:genetics*
D017931:DNA Primers; C507924:JAK2 protein, human; D053614:Janus Kinase 2